HIV Infection Clinical Trial
Official title:
Connect to Protect (C2P) Partnerships for Youth Prevention Interventions: Phase II
This is Phase II of a three stage project whose overall goals are to develop viable
community-based HIV prevention interventions and to form and maintain the necessary
community collaborations to support such Adolescent Trials Network (ATN) research
activities.
This phase will describe specific locations within high-risk areas where youth, ages 12-24,
spend time. HIV risk behaviors, social networking patterns and HIV prevalence among youth at
these venues will be assessed by administering anonymous computerized interviews to eligible
and willing youth. This information will be shared with community partners during scheduled
working group meetings.
This is Phase II of a three stage project whose overall goals are to develop viable
community-based HIV prevention interventions and to form and maintain the necessary
community collaborations to support such ATN research activities.
During this phase, each ATN site will gather additional information within high-risk areas
and solicit community partner input to ultimately pinpoint the specific locations where
at-risk youths, ages 12-24, may be recruited for interventions. This will be done by the
following methods:
Venues will be identified by HIV+ youth at the ATN site by participation in an anonymous
computerized interview. Site staff will then perform brief venue interviews (BVIs) at
selected venues to assess the potential yield of youths 12-24 years old. Community partners
will also provide the site staff with information on known high-risk venues. High-risk
venues will further be identified by the results of anonymous computerized interviews and
HIV assays obtained from eligible and willing youth participants at the venues. The
interviews will gather information on HIV risk behaviors, social networking patterns and HIV
prevalence among youths at these venues. This information will be shared with community
partners during scheduled working group meetings.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT02135419 -
Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions
|
Phase 3 | |
| Active, not recruiting |
NCT02663856 -
My Smart Age With HIV: Smartphone Self-assessment of Frailty
|
||
| Terminated |
NCT02743598 -
Liraglutide for HIV-associated Neurocognitive Disorder
|
Phase 4 | |
| Completed |
NCT02921516 -
Growing Up: Intervening With HIV-Positive Adolescents in Resource-Poor Settings
|
N/A | |
| Completed |
NCT02846402 -
Impact of HIV Self-testing Among Female Sex Workers in Kampala, Uganda
|
N/A | |
| Completed |
NCT02663869 -
Aging With HIV at Younger vs Older Age: a Diverse Population With Distinct Comorbidity Profiles
|
||
| Completed |
NCT02659306 -
Metformin Immunotherapy in HIV Infection
|
Phase 1 | |
| Completed |
NCT02564341 -
Targeting Effective Analgesia in Clinics for HIV - Intervention
|
N/A | |
| Active, not recruiting |
NCT02302950 -
A Retrospective Analysis of Raltegravir Use in Minority HIV Infected Women in Houston, Texas
|
N/A | |
| Terminated |
NCT01902186 -
Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir
|
Phase 4 | |
| Terminated |
NCT02109224 -
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
|
Phase 1 | |
| Completed |
NCT01852942 -
Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV
|
Phase 2 | |
| Completed |
NCT01830595 -
Lactoferrin Treatment in HIV Patients
|
Phase 2 | |
| Completed |
NCT02269605 -
Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral Treatment
|
Phase 1 | |
| Completed |
NCT02527135 -
Text Messaging to Improve HIV Testing Among Young Women in Kenya
|
N/A | |
| Completed |
NCT01946217 -
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
|
N/A | |
| Completed |
NCT02118168 -
Observational Study for the Extended Follow-up of the Patients Enrolled in the Therapeutic Clinical Trial ISS T-002
|
N/A | |
| Completed |
NCT02525146 -
Birmingham Access to Care Study
|
N/A | |
| Active, not recruiting |
NCT02602418 -
Neural Correlates of Working Memory Training for HIV Patients
|
N/A | |
| Completed |
NCT01702974 -
Immune Reconstitution in HIV Disease (IREHIV)
|
Phase 2 |